C$70 Million (cad)

Tilray

Buy-side

Fairness Opinion, January 2019

Acquisition of Natura Naturals Holdings Inc.

Tilray is pioneering the future of medical cannabis research, cultivation, processing and distribution globally, and it intends to become a leader in the adult-use cannabis market in Canada. Tilray currently produces and sells its products in accordance with the Access to Cannabis for Medical Purposes Regulations (ACMPR) as set by Health Canada, Canada’s federal department of health. Tilray supplies high-quality cannabis products to tens of thousands of patients across the globe through its subsidiaries in Australia, Canada, Germany and Portugal and through established pharmaceutical distributors.

More Like This

Jul 2020
$300 Million

Exclusive Option to Acquire Tizona Therapeutics

Financial Advisor

View Details
Jun 2020

Merger with MYOS RENS Technology, Inc.

Financial Advisor

View Details
Jun 2020
$1.4 Billion

Acquisition of ArcherDX, Inc.

Financial Advisor

View Details